The Company has enclosed herewith intimation for closure of trading window for the quareter ended 30.06.2026

Krebs Biochemicals & Industries Limited CIN : L24110AP1991PLC103912 June 22, 2026 To, To, BSE Limited National Stock Exchange of India Ltd P J Towers, Dalal Street, Exchange Plaza, Bandra Kurla Complex, Fort, Mumbai- 400001. Bandra(E), Mumbai- 400051. BSE Scrip Code 524518 NSE Scrip Code: KREBSBIO Dear Sir/ Madam, Sub: Closure of Trading Window This is to inform that pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, trading window for dealings in securities of the Company shall remain closed with effect from close of business hours on June 30, 2026 un-till 48 hours after the declaration of Unaudited Financial Results for 1st quarter ended June 30, 2026 for promoters, directors, designated persons, their immediate relatives and all connected persons covered under the said code. The date of the Board meeting for consideration of the said Unaudited Financial Results would be intimated to the stock exchanges in due course of time. This is for the information please. Thanking you, Yours Faithfully For Krebs Biochemicals & Industries Limited Rakesh R Kalbate Company Secretary & Compliance Officer A66666 Regd. Office : Kothapalli (V), Kasimkota (M), Anakapalli, Visakhapatnam, Andhra Pradesh-531 031 Tel : 040-66808040 E-mail com_sec@krebsbiochem.com Website- www.krebsbiochem.com